Organized Providers
About Organized Providers
The Organized Providers Service examines the healthcare delivery trends reshaping provider organizations, with a focus on value-based care, population health, quality initiatives, and evolving accountability models. Through research with integrated delivery networks (IDNs), HIRC provides insights into the priorities, challenges, and decision-making processes influencing pharmaceutical engagement and product access within organized provider settings.
Latest Research Insights
For more information, or to subscribe, contact:
(610) 888-9417
Research Archive
2026 Research
Integrated Delivery Networks: Evaluation of Pharmaceutical Manufacturer Programs and Support Offerings
October 2026. Examines IDNs' "Most Valuable" manufacturer program nominations provides ratings of 25+ manufacturers in Presence and Value of Programs/Resources as well as the frequency of support across eight unique program categories, and identifies opportunities for future support.
Profiles of Select Industry-Leading IDNs
June 2026. Detailed profiles of 20 select, industry-leading IDNs, including size, volume, and financial metrics, strategic imperatives, and pharmacy capabilities.
Integrated Delivery Networks: Market Landscape and Strategic Imperatives
May 2026. Examines the top market trends driving IDN decision-making and strategy. Provides an update on IDN risk-bearing activities, including system-led health plans, direct-to-employer arrangements, and participation in payer value-based payment programs. Reviews IDNs’ most urgent strategic imperatives for 2026 and efforts to increase access to care along the continuum.
Integrated Delivery Networks: Direct Contracting and Medication Management
April 2026. Reviews trends in direct contracting between IDNs and pharmaceutical manufacturers, including contract types and prevalence across 30+ therapeutic areas. Examines health systems’ influence over physician prescribing behavior through standardized treatment pathway development, inpatient and outpatient formularies, and enforcement and compliance mechanisms.
Integrated Delivery Networks: Manufacturer Account Engagement and Competitive Positioning
March 2026. Examines manufacturer account engagement and access to IDN decision-makers, presence with IDN accounts, as well as IDN nominations for overall manufacturer “Partner of Choice” benchmark ratings of 30+ manufacturers in relational status from distant/tactical to collaborative/strategic.
Integrated Delivery Networks: Evaluation of Pharmaceutical Manufacturer Account Managers
February 2026. Provides IDN decision-makers nominations of a best-in-class IDN/systems account managers, ratings of 25+ account management teams in presence and overall quality, and evaluates account manager performance across six critical competencies. Identifies opportunities for key account managers to enhance engagement with IDNs/health systems.
2025 Research
Integrated Delivery Networks: Quality and Population Health Management Goals and Initiatives
October 2025. Reviews integrated delivery networks’ (IDN) quality benchmark systems, quality goals/objectives by disease state, and population health management capabilities.
Integrated Delivery Networks: Evaluation of Pharmaceutical Manufacturer Programs and Support Offerings
Integrated Delivery Networks: Market Landscape and Strategic Imperatives
Integrated Delivery Networks: Direct Contracting and Medication Management
Integrated Delivery Networks: Manufacturer Account Engagement and Competitive Positioning
Integrated Delivery Networks: Evaluation of Pharmaceutical Manufacturer Account Managers
Integrated Delivery Networks: Quality and Population Health Management Goals and Initiatives
Go Deeper:
Organized Providers
The Organized Providers Service helps pharmaceutical teams better understand the trends, priorities, and organizational dynamics shaping today’s integrated delivery network (IDN) environment and the broader healthcare delivery landscape.
Through ongoing research with IDN leaders, HIRC provides independent insights into value-based care, quality improvement initiatives, medication management, and other factors influencing healthcare decision-making and pharmaceutical engagement.
For more information or to subscribe, contact Karen Ernst via email.
HIRC employs a triangulated research methodology that combines primary survey research, in-depth stakeholder interviews, and secondary market analysis to provide a comprehensive understanding of healthcare stakeholder perspectives, market dynamics, and emerging industry trends.
Research includes integrated delivery network executives, pharmacy and medical leaders, and quality and population health leaders and covers the following topics:
- Market Landscape Trends and Key Account Profiles
- Benchmarking Manufacturer Relational Status with IDNs, Account Manager Engagement, and Program/Support Offerings
- Medication Management and Direct Contracting
- Quality & Population Health Initiatives
Subscribers can better understand the evolving role of integrated delivery networks, benchmark manufacturer engagement and support, monitor trends influencing provider decision-making, and make more informed decisions regarding customer strategy and stakeholder engagement.